Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassays

Schuetz, 2007, Biomarkers to improve diagnostic and prognostic accuracy in systemic infections, Curr. Opin. Crit. Care, 13, 578, 10.1097/MCC.0b013e3282c9ac2a Schuetz, 2009, Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections—hope for hype?, Swiss Med. Wkly., 139, 318 Snider, 1997, Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization, J. Investig. Med., 45, 552 Stolz, 2007, Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy, Chest, 131, 9, 10.1378/chest.06-1500 Schuetz, 2007, Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial, B.M.C. Health Serv. Res., 7, 102, 10.1186/1472-6963-7-102 Christ-Crain, 2006, Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial, Am. J. Respir. Crit. Care Med., 174, 84, 10.1164/rccm.200512-1922OC Christ-Crain, 2004, Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet, 363, 600, 10.1016/S0140-6736(04)15591-8 Briel, 2008, Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care, Arch. Intern. Med., 168, 2000, 10.1001/archinte.168.18.2000 Nobre, 2008, Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial, Am. J. Respir. Crit. Care Med., 177, 498, 10.1164/rccm.200708-1238OC Steinbach, 2004, Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System, Clin. Chem. Lab. Med., 42, 440, 10.1515/CCLM.2004.077 Hubl, 2003, Evaluation of a fully automated procalcitonin chemiluminescence immunoassay, Clin. Lab., 49, 319 de Wolf, 2009, Comparison of a new procalcitonin assay from Roche with the established method on the Brahms Kryptor, Clin. Chem., 55, 1043, 10.1373/clinchem.2008.117655 Bablok, 1988, A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III, J. Clin. Chem. Clin. Biochem., 26, 783 Dewitte, 2002, Application of the Bland–Altman plot for interpretation of method-comparison studies: a critical investigation of its practice, Clin. Chem., 48, 799, 10.1093/clinchem/48.5.799 Masia, 2005, Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index, Chest, 128, 2223, 10.1378/chest.128.4.2223 Barassi, 2004, Biological variation of procalcitonin in healthy individuals, Clin. Chem., 50, 1878, 10.1373/clinchem.2004.037275 Schuetz, 2009, A Procalcitonin Algorithm versus a Clinical Guideline Algorithm for Antibiotic Treatment in Lower Respiratory Tract Infections: The Randomized-controlled Multicenter ProHOSP Trial, JAMA, 302, 1059, 10.1001/jama.2009.1297